Pharmaceutical and cosmetic companies are the number one consumers of this tech, but other industries are taking notice.
Pharmaceutical and cosmetic companies are the number one consumers of this tech, but other industries are taking notice.
Organ-on-chip market for drug testing expected to see tenfold growth to $1.3 trillion by 2032
